Benefit-sharing from DSI rests on the provider country's national framework. Where it requires bilateral benefit-sharing for DSI, those terms apply. Where it gives effect to the CBD multilateral mechanism, users of its publicly available DSI should share benefits through it: all users non-monetary benefits, as appropriate, and commercial users above set size thresholds also monetary contributions to the Cali Fund. Where it is silent on DSI, the position is not yet settled: check with the country's competent national authority, through the ABS service. Any terms agreed when the genetic resources were accessed still apply. Access and benefit-sharing questions are handled by the ABS service, not by the DataBank. Learn more →
Light/fluorescence microscopy of cells & tissues, and electron/cryo-EM imaging of macromolecular structures — a metadata catalog with a durable link back to the source archive, not a hosted image gallery. These are primary research datasets (often multi-GB to multi-TB), so this platform never downloads or stores the underlying imaging data itself. Datasets already in either source archive are ingested via accession paste/CSV at /mirroring by a Continental Admin (no automated harvesting — neither source archive supports geography-filterable search); a dataset not yet in either archive can instead be submitted directly below by any node operator, for Continental Admin review. Either way, whoever submits an accession or a self-submitted dataset is the one asserting African origin — this platform does not verify it.
Nontuberculous mycobacteria (NTM) infections are increasing in incidence and mortality worldwide. This study investigates the roles of Toll-like receptor 2 (TLR2) and the microbiome in orchestrating immune responses in NTM infection. Using a zebrafish larval model, we studied uptake of two NTM strains (Mycobacterium avium and M. marinum) through the gastrointestinal (GI) tract. We performed bacterial immersion experiments with these patho-gens using tlr2 mutant and wild-type zebrafish larvae in both germ-free (GF) and microbiome-colonized conditions. In wild-type microbiome-colonized larvae, M. avium predominantly localizes in the posterior gut, in contrast to an anterior-biased distribution for M. marinum. We found that both M. avium and M. marinum disseminate to posteri-or tissues after 2.5 days of immersion infection. Robotic gut microinjection confirms the protective roles of TLR2 and the microbiome against proliferation of M. avium and M. marinum. Expression analysis of downstream genes indicate that patterns of TLR2-dependent gene regulation differ between the two NTM species and show that the presence or absence of the microbiome differentially influences specific transcriptional responses to infection. Macrophage ablation studies show that macrophages facilitate dissemination of gut bacteria to distal tissues. Quantification of macrophages containing bacteria throughout the body show that the uptake of bacteria by mac-rophages depends on TLR2, but not on the microbiome. Using the same approach, TLR2 chemical antagonist treatment confirms the results observed in tlr2 mutant larvae. Live imaging of macrophage trajectories after bacte-rial gut microinjection show that macrophage motility after infection is impaired in tlr2 mutant larvae compared to the wild type. Notably, the effect of TLR2 on macrophage motility differs between GF and microbiome-colonized conditions. Our findings provide new insights into the coordinated roles of TLR2 signaling and the microbiome in controlling infection of mycobacteria via the gut and underscore the importance of TLR2 in macrophage function during mycobacterial gut infection
Pseudomonas aeruginosa breaches respiratory epithelia through goblet cell invasion in a microtissue model
BioImage Archive:S-BIAD1083 · A. Leoni Swart (University of Basel) · Pseudomonas tremae
While commensal bacteria generally respect natural barriers of the human body, pathogens are able to breach epithelia, invade deeper tissue layers and cause life-threatening infections. Pseudomonas aeruginosa, an opportunistic human pathogen, is a leading cause of severe hospital-acquired pneumonia, with mortality rates up to 50% in mechanically ventilated patients1–3. Effective colonization and breaching of lung mucosa are hallmarks of P. aeruginosa pathogenesis4. Although virulence factors and behavioral strategies of P. aeruginosa have been described5,6, it has remained unclear how this pathogen disseminates on functional mucosal surfaces, how it avoids mucociliary clearance and how it invades the tissue barrier. Using fully differentiated human lung epithelia, we demonstrate that P. aeruginosa efficiently spreads on the apical tissue surface before it breaches epithelia by preferentially invading mucus secreting goblet cells. Internalization leads to host cell death and expulsion and the formation of ruptures of the epithelial barrier. Rupture sites are rapidly colonized by extracellular bacteria through active chemotaxis, leading to increasing tissue damage and successful pathogen translocation to the unprotected basolateral side of the epithelium. We show that cell invasion is promoted by two Type-6 toxin secretion systems (T6SS), while Type-3 (T3SS) mediates cell death of infected goblet cells. T3SS mutants invade goblet cells normally, but internalized bacteria fail to trigger goblet cell expulsion and instead show unrestrained intracellular replication. While the effective shedding of infected host cells reveals potent tissue protection mechanisms, the discovery of an intracellular lifestyle of P. aeruginosa in pseudostratified human lung epithelia provides new entry points into investigating the intersection of antibiotic and immune mechanisms during lung infections. By demonstrating that P. aeruginosa uses a combination of specific virulence factors and collective behavior to invade goblet cells and breach the lung tissue barrier from within, these studies reveal novel mechanisms underlying lung infection dynamics under physiological conditions.
Nontuberculous mycobacteria (NTM) infections are increasing in incidence and mortality worldwide. This study investigates the roles of Toll-like receptor 2 (TLR2) and the microbiome in orchestrating immune responses in NTM infection. Using a zebrafish larval model, we studied uptake of two NTM strains (Mycobacterium avium and M. marinum) through the gastrointestinal (GI) tract. We performed bacterial immersion experiments with these patho-gens using tlr2 mutant and wild-type zebrafish larvae in both germ-free (GF) and microbiome-colonized conditions. In wild-type microbiome-colonized larvae, M. avium predominantly localizes in the posterior gut, in contrast to an anterior-biased distribution for M. marinum. We found that both M. avium and M. marinum disseminate to posteri-or tissues after 2.5 days of immersion infection. Robotic gut microinjection confirms the protective roles of TLR2 and the microbiome against proliferation of M. avium and M. marinum. Expression analysis of downstream genes indicate that patterns of TLR2-dependent gene regulation differ between the two NTM species and show that the presence or absence of the microbiome differentially influences specific transcriptional responses to infection. Macrophage ablation studies show that macrophages facilitate dissemination of gut bacteria to distal tissues. Quantification of macrophages containing bacteria throughout the body show that the uptake of bacteria by mac-rophages depends on TLR2, but not on the microbiome. Using the same approach, TLR2 chemical antagonist treatment confirms the results observed in tlr2 mutant larvae. Live imaging of macrophage trajectories after bacte-rial gut microinjection show that macrophage motility after infection is impaired in tlr2 mutant larvae compared to the wild type. Notably, the effect of TLR2 on macrophage motility differs between GF and microbiome-colonized conditions. Our findings provide new insights into the coordinated roles of TLR2 signaling and the microbiome in controlling infection of mycobacteria via the gut and underscore the importance of TLR2 in macrophage function during mycobacterial gut infection
Two antagonistic response regulators control Pseudomonas aeruginosa polarization during mechanotaxis
BioImage Archive:S-BSST1007 · Marco Kühn (École Polytechnique Fédérale de Lausanne) · Pseudomonas amygdali pv. morsprunorum
Source data for figures corresponding to the study: Two antagonistic response regulators control Pseudomonas aeruginosa polarization during mechanotaxis. DOI: https://doi.org/10.15252/embj.2022112165
Microbial keratitis, infection of the cornea, cause by ExotoxinU (ExoU) strains of Pseudomonas aeruginosa have a poor clinical outcome and response to antimicrobials. ExoU, a phospholipase, is secreted directly into host cells, causing their lysis. A screen of 3,034 FDA-approved compounds identified zinc pyrithione (Zp), bismuth subcitrate (Bis), and polymyxin B (Pol) as lead inhibitors of ExoU selectively inhibiting it without affecting human PLA2s or bacterial viability. The compounds have distinct inhibitory mechanisms: Zp disrupted ExoU oligomerization and protein stability; Bis impaired phosphatidylinositol 4,5-bisphosphate-dependent membrane association; Pol directly inhibited catalysis via its lipid-peptide architecture. Compound combinations enhanced ExoU inhibition in vitro to nanomolar concentrations. In mammalian cells, Bis and Pol promoted lysosomal trafficking and degradation of ExoU. Using a high-throughput microscopy platform, we screened 53 P. aeruginosa keratitis isolates, confirming broad efficacy of these inhibitors in exoU⁺ strains. Therapeutic efficacy was evaluated in ex vivo porcine corneas, Galleria mellonella, and in vivo mouse keratitis models. Topical delivery of ExoU inhibitors, particularly in combination, significantly reduced corneal opacity, ulceration, and stromal damage in porcine corneas without affecting bacterial load. In Galleria, compound combinations significantly maintained larval health, improved larval survival and delayed mortality. In a mouse eye infection model, combinatorial treatment reduced disease severity and preserved tissue viability without altering bacterial burden. These findings validate ExoU as a druggable virulence factor and support the repurposing of these compounds as an anti-virulence strategy for the treatment of P. aeruginosa infections in humans and veterinary medicine.
Efficient colonisation of host tissue surfaces is a prerequisite for bacterial infection. In the human pathogen Pseudomonas aeruginosa, the second messengers cAMP and c-di-GMP regulate surface behaviours and virulence, but how these pathways are coordinated during tissue infection has remained unclear. Here we demonstrate that cAMP and c-di-GMP establish mutually exclusive signalling states at the single-cell level, generating distinct subpopulations of motile and surface-attached cells through pathway-specific control of type IV pili (T4P). Initial surface contact triggers an increase in c-di-GMP, activating FimW and driving stable attachment via bipolar T4P formation. This state is progressively replaced by cAMP, which inactivates FimW-dependent attachment and induces FimX-mediated T4P polarisation, surface motility and virulence activation. The resulting signalling transition enforces coexisting subpopulations, with attached cells gradually displaced by spreading cells. Using a human airway tissue model, we show that both T4P-mediated adhesion and twitching motility are required for invasion and tissue damage. Based on this, we propose that reciprocal cAMP-c-di-GMP signalling coordinates complementary T4P functions to optimise P. aeruginosa surface colonisation and infection.
Antagonistic second messenger signalling coordinates Pseudomonas aeruginosa surface colonization and virulence
BioImage Archive:S-BIAD3989 · (University of Basel) · Pseudomonas protegens
Efficient colonisation of host tissue surfaces is a prerequisite for bacterial infection. In the human pathogen Pseudomonas aeruginosa, the second messengers cAMP and c-di-GMP regulate surface behaviours and virulence, but how these pathways are coordinated during tissue infection has remained unclear. Here we demonstrate that cAMP and c-di-GMP establish mutually exclusive signalling states at the single-cell level, generating distinct subpopulations of motile and surface-attached cells through pathway-specific control of type IV pili (T4P). Initial surface contact triggers an increase in c-di-GMP, activating FimW and driving stable attachment via bipolar T4P formation. This state is progressively replaced by cAMP, which inactivates FimW-dependent attachment and induces FimX-mediated T4P polarisation, surface motility and virulence activation. The resulting signalling transition enforces coexisting subpopulations, with attached cells gradually displaced by spreading cells. Using a human airway tissue model, we show that both T4P-mediated adhesion and twitching motility are required for invasion and tissue damage. Based on this, we propose that reciprocal cAMP-c-di-GMP signalling coordinates complementary T4P functions to optimise P. aeruginosa surface colonisation and infection.
Introduction of artificial plants has no detrimental or beneficial effects on laboratory zebrafish husbandry but limits available swimming space
BioImage Archive:S-BIAD2980 · (BfR - Federal Institute for Risk Assessment) · Mycobacterium tuberculosis
Abstract
There is a broad consensus that husbandry conditions of laboratory animals need constant improvement to guarantee optimal animal welfare and research data quality. Zebrafish (Danio rerio) as one of the main animal models in biomedicine and toxicology are currently kept in barren tanks in most experimental setups, as well as in animal husbandry. Structural enrichment with artificial plants is currently discussed as a potential refinement measure to provide a more diverse environment. Other reports have shown that this can reduce stress or anxiety and improve cognitive abilities, survival rate and fertility in these animals. Still, concerns remain regarding its long-term benefits and drawbacks. Therefore, we introduced artificial plants in our husbandry tanks, and evaluated over a one-year period if in our specific system the benefits would outweigh the risks. When we compared pairwise 16 tanks that were non-enriched or enriched with artificial plants, we saw no significant difference in terms of zebrafish survival rate during rearing, sex ratio, fertility or pathogen burden. When analyzing zebrafish behavior in their 8 L home-tanks, we saw avoidance of the area close to the plants and a place preference for the open water in the middle or opposite side of the tank. This effect got more pronounced at lower holding densities. In summary, we found that introducing structural enrichment to our specific zebrafish facility carried low cost, no detrimental effects for the animals despite a reduction of their free-swimming space but at the same time benefits were difficult to determine in our readouts as our survival rates already were very high without these measures. We would like to encourage others to evaluate new forms of enrichment in their facilities to ensure a broader discussion on its potential long-term benefits in zebrafish husbandry systems.
Microbial keratitis, infection of the cornea, cause by ExotoxinU (ExoU) strains of Pseudomonas aeruginosa have a poor clinical outcome and response to antimicrobials. ExoU, a phospholipase, is secreted directly into host cells, causing their lysis. A screen of 3,034 FDA-approved compounds identified zinc pyrithione (Zp), bismuth subcitrate (Bis), and polymyxin B (Pol) as lead inhibitors of ExoU selectively inhibiting it without affecting human PLA2s or bacterial viability. The compounds have distinct inhibitory mechanisms: Zp disrupted ExoU oligomerization and protein stability; Bis impaired phosphatidylinositol 4,5-bisphosphate-dependent membrane association; Pol directly inhibited catalysis via its lipid-peptide architecture. Compound combinations enhanced ExoU inhibition in vitro to nanomolar concentrations. In mammalian cells, Bis and Pol promoted lysosomal trafficking and degradation of ExoU. Using a high-throughput microscopy platform, we screened 53 P. aeruginosa keratitis isolates, confirming broad efficacy of these inhibitors in exoU⁺ strains. Therapeutic efficacy was evaluated in ex vivo porcine corneas, Galleria mellonella, and in vivo mouse keratitis models. Topical delivery of ExoU inhibitors, particularly in combination, significantly reduced corneal opacity, ulceration, and stromal damage in porcine corneas without affecting bacterial load. In Galleria, compound combinations significantly maintained larval health, improved larval survival and delayed mortality. In a mouse eye infection model, combinatorial treatment reduced disease severity and preserved tissue viability without altering bacterial burden. These findings validate ExoU as a druggable virulence factor and support the repurposing of these compounds as an anti-virulence strategy for the treatment of P. aeruginosa infections in humans and veterinary medicine.
LeishTag: Leishmania protein subcellular localisation through the life cycle
BioImage Archive:S-BIAD4306 · (University of Oxford) · Mycobacterium tuberculosis TKK_03_0037
LeishTag is a sub-project of the LeishGEM project aiming to determine where the proteins of the unicellular eukaryotic pathogen Leishmania mexicana localise within the cell. Endogenous tagging of proteins at the N or C terminus with mNG, targeting Leishmania-specific proteins in both the promastigote and amastigote life cycle stages which lack a Trypanosoma brucei ortholog or with low sequence similarity (<20%) than the T. brucei ortholog, thereby complementing the TrypTag project's annotations.